Remove tag governance
article thumbnail

STAT+: Lawmakers tell Pfizer CEO to ‘back off’ on planned price hike for Covid-19 vaccine

STAT News

argued the planned price tag is nearly four times the current $30 price paid by the U.S. government and also represents a 10,000% markup over what some researchers have calculated as the cost to produce the vaccine. A pair of U.S. ” In their letter, U.S. Elizabeth Warren (D-Mass.) Peter Welch (D-Vt.)

article thumbnail

Big numbers blur policy ambitions

Scienmag

Government policies often are presented with hefty price tags, but people often zone out as more zeros are added to the total cost.

80
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds February 2, 2024: Strategies for Improving Public Understanding of FDA and the Products It Regulates…Why Should We Care, and What Might We Do? (Susan C. Winckler, RPh, Esq)

Rethinking Clinical Trials

This work is important because the digital health information environment and limited public trust in government institutions represent pressing challenges for FDA. Potential strategies: “Prebunk” health misinformation; collaborate with other organizations (within and beyond government); monitor and respond to misunderstandings.

article thumbnail

Medicare savings won’t make a dent in healthcare costs

World of DTC Marketing

The drug industry is trying to convince voters that government negotiations with drug companies will lead to less innovation. But even though the government may be saving money, ordinary taxpayers probably won’t see any discounts. The problem is that voters don’t believe that pitch.

Drugs 222
article thumbnail

Anti-Counterfeiting Technologies in Healthcare

Roots Analysis

Examples of such technologies include DNA Taggants (a unique DNA tag used in the product / packaging that can be scanned using a designated instrument / equipment), invisible printing technologies, digital watermark technologies and hidden markers / print technologies.

article thumbnail

Grand Rounds Ethics and Regulatory Series November 11, 2022: Data Sharing and Pragmatic Clinical Trials: Law & Ethics Amidst a Changing Policy Landscape (Stephanie Morain, PhD, MPH; Kayte Spector-Bagdady, JD, MBioethics)

Rethinking Clinical Trials

The government has made an interesting transition to focusing on sharing data that are generated in research for secondary analyses but then shifted to wanting access to data from the primary analysis. Discussion Themes. Can you better define data sharing, is it the publication? pctGR, @Collaboratory1.

article thumbnail

Grand Rounds Ethics and Regulatory Series September 9, 2022: Building An Academic Learning Health System: Why Is It So Hard? (Steven Joffe, MD, MPH)

Rethinking Clinical Trials

How does your org approach governance and oversight of learning within your LHS? How are patients and families included in governance of learning within your LHS? The key questions asked during the interviews were: In your view what defines an outstanding LHS? From these questions three main challenges emerged. Learn more.